Online Blood Sampling

An automated system withdraws small blood volumes through vascular access and transfers them to an integrated or connected analyzer. This links each collection event to measurement without the delay of separate manual processing. A series of closely spaced readings can therefore reveal changing physiology or drug concentrations during the observation period.

Vascular access provides the route for repeated automated withdrawal, while the analyzer converts each collected sample into a biomarker result. Keeping these functions connected helps align sampling with measurement and reduces the time between them. That coordination is especially relevant when investigators need to follow glucose, gases, electrolytes, or drug concentrations as conditions change.

Compared with isolated manual samples, Online Blood Sampling can produce a denser sequence of measurements while limiting repeated blood collection by hand. This distinction matters when a single result may miss a short-lived physiological or pharmacological change. In pharmacokinetic studies, closely spaced concentrations can better describe how drug levels evolve over the monitored period.

Usefulness depends on obtaining samples continuously or at closely spaced intervals, withdrawing small volumes through vascular access, and linking collection to an analyzer capable of measuring the biomarker of interest. When these elements are coordinated, the system can reduce result delays and support more responsive assessment of changing physiological states.

First, establish vascular access and connect it to the monitoring setup. The system then withdraws small blood volumes continuously or at close intervals. Each sample is routed to an integrated or connected analyzer, which measures selected biomarkers. The resulting near-real-time readings can be reviewed as a time-resolved record of physiological or drug-related changes.

Its documented uses include pharmacokinetic studies, intensive care monitoring, and research requiring dynamic measurements of glucose, blood gases, electrolytes, or drug concentrations. In these settings, frequent automated results can help characterize changing physiology or exposure to a drug while limiting the need for repeated manual sampling.

Near-real-time biomarker results provide a more current view of a patient's physiological state than delayed results would provide. In intensive care and other monitored settings, this time-resolved information can help clinicians assess changes and guide treatment decisions. Its value comes from combining frequent measurements with shorter delays rather than relying on a single isolated result.